Insider · CIK 0001465143

DP VIII Associates, L.P.

Reports to the SEC for 12 companies · BOSTON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001465143

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-08-23	BNGOBionano Genomics, Inc.C Conversion	10% Owner	CConversion	+2,505 sh	$4.59	+$11.5K	6,891
2018-08-23	BNGOBionano Genomics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−50.5K sh	—	—	0
2018-08-23	BNGOBionano Genomics, Inc. · Series B-1 Preferred StockC Conversion	10% Owner	CConversion	−22.2K sh	—	—	0
2018-08-23	BNGOBionano Genomics, Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−40.3K sh	—	—	0
2018-08-23	BNGOBionano Genomics, Inc. · Series D Preferred StockC Conversion	10% Owner	CConversion	−47.5K sh	—	—	0
2018-08-23	BNGOBionano Genomics, Inc. · Series D-1 Preferred StockC Conversion	10% Owner	CConversion	−27.3K sh	—	—	0
2018-08-23	BNGOBionano Genomics, Inc. · Convertible Promissory NoteC Conversion	10% Owner	CConversion	—	—	—	0
2018-08-23	BNGOBionano Genomics, Inc.C Conversion	10% Owner	CConversion	+4,386 sh	—	—	4,386
2017-12-18	Dicerna Pharmaceuticals IncC Conversion	10% Owner	CConversion	+12.4K sh	$3.19	+$39.7K	25,448
2017-12-18	Dicerna Pharmaceuticals IncA Award	10% Owner	AAward	+282 sh	—	—	25,730
2017-12-18	Dicerna Pharmaceuticals IncRedeemable Convertible Preferred StockC Conversion	10% Owner	CConversion	−368 sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−7,333 sh	—	—	0
2017-04-11	Dicerna Pharmaceuticals IncRedeemable Convertible Preferred StockP Purchase	10% Owner	PPurchase	+368 sh	$100.00	+$36.8K	368
2016-03-08	SNDXSyndax Pharmaceuticals IncC Conversion	10% Owner	CConversion	+5,641 sh	—	—	5,641
2016-03-08	SNDXSyndax Pharmaceuticals Inc · Series B-1 Preferred StockC Conversion	10% Owner	CConversion	−2,967 sh	—	—	0
2016-03-08	SNDXSyndax Pharmaceuticals Inc · Series C-1 Preferred StockC Conversion	10% Owner	CConversion	−2,674 sh	—	—	0
2015-06-30	GKOSGLAUKOS CorpC Conversion	10% Owner	CConversion	+6,501 sh	—	—	6,501
2015-06-30	GKOSGLAUKOS Corp · Series E Preferred StockC Conversion	10% Owner	CConversion	−4,371 sh	—	—	0
2015-06-30	GKOSGLAUKOS Corp · Series F Preferred StockC Conversion	10% Owner	CConversion	−2,130 sh	—	—	0
2015-05-12	ATYRaTYR PHARMA INCC Conversion	10% Owner	CConversion	+13.4K sh	—	—	13,414
2015-05-12	ATYRaTYR PHARMA INC · Series C Preferred StockC Conversion	10% Owner	CConversion	−90.1K sh	—	—	0
2015-05-12	ATYRaTYR PHARMA INC · Series D Preferred StockC Conversion	10% Owner	CConversion	−11.2K sh	—	—	0
2015-05-12	ATYRaTYR PHARMA INC · Series E Preferred StockC Conversion	10% Owner	CConversion	−6,581 sh	—	—	0
2014-11-17	Durata Therapeutics, Inc.D Disposition to Issuer	10% Owner	DDisposition to Issuer	−22.3K sh	—	—	0
2014-10-21	ATRAAtara Biotherapeutics, Inc.C Conversion	10% Owner	CConversion	+14K sh	—	—	14,049
2014-10-21	ATRAAtara Biotherapeutics, Inc.P Purchase	10% Owner	PPurchase	+1,841 sh	$11.00	+$20.3K	15,890
2014-10-21	ATRAAtara Biotherapeutics, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−9,443 sh	—	—	0
2014-10-21	ATRAAtara Biotherapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−4,606 sh	—	—	0
2014-08-18	OTONOMY, INC.Series B Preferred StockC Conversion	10% Owner	CConversion	−3,238 sh	—	—	0
2014-08-18	OTONOMY, INC.F Tax Payment	10% Owner	FTax Payment	−277 sh	$16.00	−$4,432	11,715
2014-08-18	OTONOMY, INC.M Exercise/Conversion	10% Owner	MExercise/Conversion	+502 sh	$8.79	+$4,412.58	11,992
2014-08-18	OTONOMY, INC.C Conversion	10% Owner	CConversion	+11.5K sh	—	—	11,490
2014-08-18	OTONOMY, INC.Series C Preferred Stock Warrant (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−502 sh	—	—	0
2014-08-18	OTONOMY, INC.Series D Preferred StockF Tax Payment	10% Owner	FTax Payment	−1,386 sh	—	—	0
2014-08-18	OTONOMY, INC.Series C Preferred StockC Conversion	10% Owner	CConversion	−6,866 sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncSeries B Preferred StockC Conversion	10% Owner	CConversion	−3,535 sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncSeries C Preferred StockC Conversion	10% Owner	CConversion	−9,469 sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncWarrantC Conversion	10% Owner	CConversion	−156 sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncWarrantC Conversion	10% Owner	CConversion	+156 sh	—	—	156
2014-02-04	Dicerna Pharmaceuticals IncC Conversion	10% Owner	CConversion	+13K sh	—	—	13,004
2013-11-04	VCYTVERACYTE, INC. · Series C Preferred StockC Conversion	10% Owner	CConversion	−5,053 sh	—	—	0
2013-11-04	VCYTVERACYTE, INC. · Series B Preferred StockC Conversion	10% Owner	CConversion	−17.7K sh	—	—	0
2013-11-04	VCYTVERACYTE, INC.C Conversion	10% Owner	CConversion	+22.7K sh	—	—	22,730
2012-07-24	Durata Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+5,777 sh	$9.00	+$52K	22,306
2012-07-24	Durata Therapeutics, Inc.C Conversion	10% Owner	CConversion	+16.5K sh	—	—	16,529
2012-07-24	Durata Therapeutics, Inc.Series A Preferred StockC Conversion	10% Owner	CConversion	−16.5K sh	—	—	0

Recent filings

Accepted (ET)
Aug 274
DP VIII Associates, L.P.0000904454-18-000524
SEC(opens sec.gov)
Dec 204
Halak Brian K0000904454-17-000741
SEC(opens sec.gov)
Dec 134
Halak Brian K0000904454-17-000720
SEC(opens sec.gov)
Apr 124
Dicerna Pharmaceuticals Inc0000904454-17-000306
SEC(opens sec.gov)
Mar 84
Syndax Pharmaceuticals Inc0000904454-16-001107
SEC(opens sec.gov)
Jul 14
GLAUKOS Corp0000904454-15-000441
SEC(opens sec.gov)
May 124
aTYR PHARMA INC0000904454-15-000288
SEC(opens sec.gov)

Companies

Address

C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE

BOSTON, NJ, 08542